The groundbreaking treatment of tirzepatide peptide represents a major advance in the management of type 2 diabetes. Different to existing drugs, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide413123.digitollblog.com/42010443/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment